College of American Pathologists Presents Abstract for Molecular Testing and Targeted Therapies for Lung Cancer at ASCO 2013 Annual Meeting
The College of American Pathologists (CAP) has partnered with the International Association for the Study of Lung Cancer (IASLC) and the Association for Molecular Pathology (AMP) to establish evidence-based guideline recommendations for the molecular analysis of lung cancers required to guide EGFR- and ALK-targeted therapies. The guideline recommendations will be presented at the American Society of Clinical Oncology (ASCO) annual meeting on Monday, June 3 in Chicago. “Molecular Testing Guideline for the Selection of Lung Cancer Patients for EGFR and ALK Tyrosine Kinase Inhibitors (